MCED Testing Enters New Diagnostic Realms
Elie Dolgin • August 4, 2023
Real-world performance data and trial results in symptomatic individuals continue to validate the promise of screening for multiple cancers with a single blood draw. However, some worry about the performance of GRAIL's commercially available multicancer early detection test in certain high-risk groups that were not the focus of early clinical development efforts.
Continue reading at Cancer Discovery.
As humans return to the Moon, researchers are trying to understand—and thwart—the biological toll of deep-space radiation.
Animals that researchers call “supersucklers” come back for their mother’s milk even after they can hunt, mate and fend for themselves.